TrialLeukemia2003

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.

M C Müller et al.PubMed ↗Publisher ↗

No numbers read from the abstract.